Ann Janet Woolcock Memorial Lecture

20 Nov 2026 08:30 09:00
Ballroom 3, Lower Ground Floor
Mycobacterial Genomics: Potential for Pulmonary NTM Disease Management
Toshiaki Kikuchi Speaker Japan
Ahmad Izuanuddin Ismail Chairperson Malaysia
Mycobacterial Genomics: Potential for Pulmonary NTM Disease Management Toshiaki Kikuchi, MD, PhD Niigata University Medical & Dental Hospital, Japan Background and Aims The incidence of pulmonary nontuberculous mycobacterial (NTM) disease is increasing worldwide, particularly in Japan, where Mycobacterium avium complex predominates. Some patients experience disease progression that requires antimicrobial treatment, whereas others remain stable without treatment for years. Because disease progression is difficult to predict, deciding when to start treatment remains challenging. We investigated whether the genomic characteristics of M. avium clinical isolates are associated with disease progression. Methods We performed whole-genome sequencing of 36 clinical M. avium isolates from patients with progressive (n = 25) or stable (n = 11) disease. Progressive disease was defined as initiation of treatment within 12 months of diagnosis, and stable disease as no treatment during this period. Comparative analyses included whole-genome alignment, phylogenetic analysis based on average amino acid identity (AAI), and single-nucleotide variant (SNV) analysis. Results Comparative genomic analysis identified a 1.4-Mb genomic inversion that distinguished two genomic types, type A and type non-A. All 15 type A isolates were from patients with progressive disease, whereas the 21 type non-A isolates were from patients with progressive (n = 10) or stable (n = 11) disease. Type A isolates also lacked genes adjacent to the inversion breakpoints, including the vapBC-5 toxin–antitoxin system, which may affect the regulation of bacterial growth. AAI-based phylogenetic analysis independently separated type A from type non-A isolates and revealed additional clusters associated with disease progression. Furthermore, SNV analysis of type non-A isolates identified variants associated with progression, including one in uvrB, a gene involved in DNA repair. Conclusion These findings suggest that genomic profiling of M. avium isolates may help predict disease progression and guide individualized treatment decisions in pulmonary NTM disease. Keywords: Nontuberculous mycobacteria, Whole-genome sequencing, Disease progression Reference: Tanaka K et al, Int J Infect Dis, 2026, 169, 108816. Disclosure Statement: The presenting author has received honoraria or consultation fees from Insmed, KYORIN Pharmaceutical, and Janssen Pharmaceutical.